Chinese innovative lung cancer drug under review by US FDA
Chinese drugmaker Innovent Biologics, Inc. and the US-based pharmaceutical firm Eli Lilly and Company announced on Tuesday that the US Food and Drug Administration (FDA) accepted for review an application ...